3D Printed Drugs Market Analysis by Types, Applications, End Users, Technology with Forecast till 2026
Wilmington, Delaware, United States, Transparency Market Research Inc.: 3D printed drugs are medicines that are designed using 3D printing technology to customize them for patients in safe and effective manner. These drugs possess unitary porous structural design that readily dissolve in the mouth, which prevent high-dosage medicines from being swallowed intact. Therefore, this type of medicine is useful for patients having swallowing difficulties such as children, elderly, and those ailing with Alzheimer’s disease, stroke complications, head or neck tumors, and other neurological disabilities.
Read Report Overview - https://www.transparencymarketresearch.com/3d-printed-drugs-market.html
Spritam (levetiracetam) tablets were the first 3D printed drug that received approval from the U.S. Food and Drug Administration (FDA). These were developed by Aprecia Pharmaceuticals. However, after Spritam’s approval, various 3D printed implants and materials that likely to be deemed acceptable by FDA for usage in the medicine industry; however, no other drugs have been announced with the approval.
Factors driving the 3D printed drugs market include rise in demand of rapid soluble drugs, increase in elderly population, rise in rate of adoption of personalized drugs, increase in production of combination medicine, and high rate of adoption of 3D printing technology. Additionally, rampant technological advancements, rise in awareness about 3D printing, and improvements in the health care infrastructure are expected to propel the 3D printed drugs market.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=59043
However, factors such as antagonistic effects pertaining to the use of these drugs, dearth of government regulations linked to these drugs, and usage of 3D printing to develop illegal drugs are estimated to hamper the market. Introduction of 3D printed drugs by several market players in developing nations and rise in health care investment in emerging countries are anticipated to create opportunities in the market during the forecast period.
Based on application, the global 3D printed drugs market can be classified into orthopedic, hearing & audibility aid, medical implants, dental, neurology and others. The neurology segment is expected to account for a major share of the global market. In terms of region, the global 3D printed drugs market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for leading share of the global market in 2017.
Get COVID-19 Analysis on 3D Printed Drugs Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=59043
Asia Pacific is expected to account for a major share of the market during the forecast period. Growth of the pharmaceutical industry in this region due to rise in GDP is a major factor propelling the market. Additionally, rise in rate of adoption of advanced health care techniques by consumers owing to the increase in disposable income is expected to propel the market in Asia Pacific.
Major players operating in the global 3D printed drugs market include 3D Printer Drug Machine, Aprecia Pharmaceuticals, Hewlett Packard Caribe, BV, LLC, GlaxoSmithKline Plc. and FabRx Ltd. FabRx Ltd. Technologies Inc., Aprecia Pharmaceuticals, LLC. are the only existing players of global 3D printed drugs market and GlaxoSmithKline (GSK) is measured to be a potential player as the organization is planning to invest significantly in this industry.
Make an Enquiry before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=59043
Organizations involved in research pertaining to 3D printed drugs are UCL School of Pharmacy, University of Glasgow, University College London, The University of Nottingham, and National University of Singapore.
More Trending Reports by Transparency Market Research –
Systemic Inflammatory Response Syndrome Treatment Market: Systemic Inflammatory Response Syndrome Treatment Market (Indication: Meningitis, Urinary Tract Infection (UTI), Pneumonia, Hemorrhage, Autoimmune Diseases, Others; End User: Hospital & Ambulatory Surgical Centers, Specialty Clinics, Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027
Burn Injury Treatment Market: Burn Injury Treatment Market (Product: Wound Care Dressings, Wound Care Devices, Biological Products, Medications; Degree of Burn: First-degree Burns, Second-degree Burns, Third-degree Burns; Treatment Type: Medications, Traditional Dressings, Advanced Dressings, Surgeries, Others; End User: Hospitals, Clinics, Home Care Settings, Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027
Atherosclerosis Drugs Market: Atherosclerosis Drugs Market (Drug Class: Anti-platelet Medications, Cholesterol Lowering Medications, Fibric Acid and Omega-3 Fatty Acid Derivatives, Beta Blockers, Angiotensin-converting Enzyme (ACE) Inhibitors, Calcium Channel Blockers, Diuretics, Others; Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027
Atopic Dermatitis Drugs Market: Atopic Dermatitis Drugs Market (Drug Class: Corticosteroids, PDE4 Inhibitors, Biologics, Skin Barrier Emollients, CNI Immunosuppressants, Others; Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027
Nonalcoholic Steatohepatitis Therapeutics Market: Nonalcoholic Steatohepatitis Therapeutics Market (Drug Type: Obeticholic Acid (OCA), Aramchol, Saroglitazar, and Elafibranor) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
Psoriasis Treatment Market: Psoriasis Treatment Market (Drug Class: TNF Inhibitors, Interleukin Inhibitors, Vitamin D Analogs, Corticosteroids, and Others; and Route of Administration: Oral, Parenteral, and Topical) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
Life Science Reagents Market: Life Science Reagents Market (Product: Chromatography Reagents, Molecular Diagnostics Reagents, Immunoassay Reagents, Clinical Chemistry Reagents, Flow Cytometry Reagents, Cell & Tissue Culture Reagents, Hematology & Hemostasis Reagents, Microbiology Reagents, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
Liquid Filled Hard Capsules Market: Liquid Filled Hard Capsules Market (Size: Large Capsules, Medium Capsules, and Small Capsules) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com